Compare SRTS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRTS | MYO |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.3M | 44.8M |
| IPO Year | 2016 | 2017 |
| Metric | SRTS | MYO |
|---|---|---|
| Price | $3.06 | $0.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $7.00 | ★ $7.67 |
| AVG Volume (30 Days) | 24.5K | ★ 648.9K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $27,482,000.00 | ★ $1,000,000,000.00 |
| Revenue This Year | $2.00 | $9.10 |
| Revenue Next Year | $34.23 | $13.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $2.66 | $0.61 |
| 52 Week High | $5.92 | $2.14 |
| Indicator | SRTS | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 54.06 | 45.95 |
| Support Level | $2.87 | $0.99 |
| Resistance Level | $3.17 | $1.13 |
| Average True Range (ATR) | 0.13 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 55.56 | 40.28 |
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.